[Opioid detoxication under general anesthesia].
Antagonist-precipitated opioid detoxification under general anaesthesia has been used extensively since its introduction in 1988. The use of antagonists was believed to shorten the detoxification period. Administration to opioid dependents is followed by a violent activation of the adrenergic system, which results in the development of an acute withdrawal syndrome in the patient. This is usually treated with clonidine. To reduce the subjective discomfort, the procedure is conducted under anaesthesia. From the existing literature, one may conclude that despite more than ten years of development there is currently no sufficient evidence of the effectiveness of antagonist-precipitated opioid detoxification under general anaesthesia conducted under modern anaesthesiological management. Randomised, clinical trials are necessary to document the advantages of this detoxification method as compared to conventional treatment.
D000768:Anesthesia, General; D019317:Evidence-Based Medicine; D006801:Humans; D008658:Inactivation, Metabolic; D007262:Infusions, Intravenous; D008991:Monitoring, Physiologic; D009270:Naloxone / Q000008:administration & dosage / Q000009:adverse effects; D009271:Naltrexone / Q000008:administration & dosage / Q000009:adverse effects; D009292:Narcotic Antagonists / Q000008:administration & dosage* / Q000009:adverse effects; D009293:Opioid-Related Disorders / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D016032:Randomized Controlled Trials as Topic
D009292:Narcotic Antagonists; D009270:Naloxone; D009271:Naltrexone
Opioidafgiftning under generel anaestesi.